Creston Health sees growth during first half of 2014

Creston Health has experienced strong year-on-year growth in the first half of 2014, having won a significant amount of new business during the period.

During the six months, the organisation's revenues rose by six percent to 10.3 million pounds, with the growth rate increasing to ten percent when calculated on a constant currency basis.

So far in 2014, the company has completed the acquisition of Liberation Unlimited and won new contracts with Sanofi, Baxter, Bayer, Pfizer and Novartis in the UK, while also claiming a total of 21 industry awards.

For the Creston group as a whole, six-month revenues came to 37.3 million pounds, up by five percent on the corresponding period of last year.

Barrie Brien, group chief executive of Creston, said: "While we remain cautious in light of the global macro-economic climate and its potential to affect our client budgets, the board confirms that current trading is in line with its expectations for the full year."

Earlier this month, it was announced that Creston Health will be rebranding as Health Unlimited, while pushing for closer collaboration between its subsidiary agencies.